(1)
MHC Class I-Presented Tumor Antigen Appraisable for T-Cell Responses Against Ovarian Cancer. Bangladesh J Pharmacol 2015, 10 (3), 524-528. https://doi.org/10.3329/bjp.v10i3.23076.